CIN-108

N/A

Report date: 2022/10/14 13:35:02
NME

Base Information

Drug NameCIN-108
Drug Alias NameCIN-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDCN1-like protein 1 inhibitors
TargetsDCN1-like protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCinRx Pharma Llc
China Registration ClassN/A

Develop Information

Active CompaniesCinRx Pharma Llc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A